Skip to content

The Effects of Autologous Platelet-rich Plasma Supplement During Sperm Cryopreservation on Post-cryopreserved Sperm Quality

The Effects of Autologous Platelet-rich Plasma Supplement During Sperm Cryopreservation

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06258759
Enrollment
20
Registered
2024-02-14
Start date
2024-01-01
Completion date
2024-12-31
Last updated
2024-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autologous Platelet-rich Plasma Supplement, Post-cryopreserved Sperm Quality, Semen Analysis, Sperm Cryopreservation

Keywords

Sperm, Platelet rich plasma, Vitrification, Cryopreservation, Semen analysis

Brief summary

Sperm cryopreservation is an essential procedure for male fertility in certain situations, like cancer, vasectomy or other obstructive surgeries, autoimmunity diseases, immunosuppressive therapeutic strategies, or when the male partner is incapable of providing sufficient spermatozoa on the day of egg retrieval. Semen cryopreservation is mainly associated with decreased viability, motility, and DNA damage of spermatozoa due to the osmotic and mechanical stresses attributed to the freezing-thaw- ing process. Sperm cryodamage mainly originates from osmotic changes, cold shock, intracellular ice crystal formation, and oxidative stress. Based on this, some protective strategies have been proposed and developed, even the addition of cryoprotectants. Recently, Platelet-rich plasma (PRP) is becoming very popular in medicine. The therapeutic effect of platelets is related to alpha granule contents. A study showed that PRP modulates ROS toxicity through a different mechanism. VEGF detoxify oxidative damage via activation of the nuclear factor (erythroid- derived 2)-like2 (Nrf2) pathway. Oxidative stress modulation and apoptosis inhibition both have an essential role during the cryopreservation process. In this case, it raises the question of whether PRP can improve the sperm quality against freeze-thawing-induced damage. Therefore, the present study aimed to examine different concentrations of PRP on frozen-thawed sperm parameters of vitality, morphology, motility and DNA fragmentation

Detailed description

* Each participant will be collected a semen and PRP. * Each semen will be separated into two specimens as the additional autologous platelet-rich plasma supplement group and control group (no adding autologous platelet-rich plasma). Both groups will undergo cryopreservation by Sperm vitrification for 14 days. * The additional autologous platelet-rich plasma supplement group: the semen will be added by 5% PRP and mixed with Sperm Freezing Medium and undergo cryopreservation by Sperm vitrification for 14 days. * The control group (no adding autologous platelet-rich plasma): the semen will be mixed with Sperm Freezing Medium and undergo cryopreservation by Sperm vitrification for 14 days. * After 14 days, the vitrified semen was transferred to a water bath of 37 °C for thawing. And analyzed Semen analysis via Computer Assisted Sperm Analysis: CASA and analyzed DNA fragmentation

Interventions

BIOLOGICALautologous platelet-rich plasma supplement

the semen of the additional autologous platelet-rich plasma supplement group will be added by 5% PRP and mixed with Sperm Freezing Medium and undergo cryopreservation by Sperm vitrification for 14 days

BIOLOGICALno autologous platelet-rich plasma supplement

the semen mixed with Sperm Freezing Medium and undergo cryopreservation by Sperm vitrification for 14 days

Sponsors

Department of Medical Services Ministry of Public Health of Thailand
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. A man who be a Rajavithi hospital clients or staff. 2. Aged 20-40 years old. 3. Has normal semen analysis. 4. Can communicate and understand Thai language very well. 5. Voluntarily participated in the research. 6. Sexual abstinence for 2-7 days.

Exclusion criteria

1. A man who ever diagnosed with infertile patient. 2. A wan who diagnosed with any hematological disease such as Coagulation disorders, Hypertension, Thrombocytopenia, Platelet dysfunction.

Design outcomes

Primary

MeasureTime frameDescription
Sperm vitality14 days after cryopreservationSperm vitality (percentage) after thawing

Secondary

MeasureTime frameDescription
Sperm motility14 days after cryopreservationSperm motility (percentage) after thawing
Sperm morphology14 days after cryopreservationSperm morphology (percentage of normal form) after thawing
DNA fragmentation14 days after cryopreservationDNA fragmentation (percentage) after thawing

Countries

Thailand

Contacts

Primary ContactChoermin Thitipatlertdech, M.D.
choermin@hotmail.com+6692-2659265
Backup ContactNisanart Booning, M.D.
tobee_b@hotmail.com+6684-1653945

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026